Issue 4, 2014

3,4,2′-Trimethoxy-trans-stilbene – a potent CYP1B1 inhibitor

Abstract

A novel series of methoxy-trans-stilbenes with 3,4-dimethoxy motifs was designed and synthesized. The inhibitory potency of 3,4-dimethoxystilbene derivatives against cytochrome P450 isozymes CYP1A1, CYP1B1 and CYP1A2 was evaluated. 3,4,2′-Trimethoxy-trans-stilbene (3,4,2′-TMS) exhibited extremely potent inhibitory action against CYP1B1 activity with an IC50 of 0.004 μM. 3,4,2′-TMS exhibited 90-fold selectivity for CYP1B1 over CYP1A1 and 830-fold selectivity for CYP1B1 over CYP1A2. However, 3,4,2′,4′-tetramethoxy-trans-stilbene appeared to be the most selective inhibitor of both CYP1B1 and CYP1A1 showing very low affinity toward CYP1A2. Complementary experimental studies and computational methods were used to explain what structural determinants decide the specific affinity of stilbene derivatives to CYP1A2 and CYP1B1 binding sites.

Graphical abstract: 3,4,2′-Trimethoxy-trans-stilbene – a potent CYP1B1 inhibitor

Supplementary files

Article information

Article type
Concise Article
Submitted
24 Oct 2013
Accepted
19 Jan 2014
First published
22 Jan 2014

Med. Chem. Commun., 2014,5, 496-501

3,4,2′-Trimethoxy-trans-stilbene – a potent CYP1B1 inhibitor

R. Mikstacka, M. Wierzchowski, Z. Dutkiewicz, A. Gielara-Korzańska, A. Korzański, A. Teubert, S. Sobiak and W. Baer-Dubowska, Med. Chem. Commun., 2014, 5, 496 DOI: 10.1039/C3MD00317E

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Spotlight

Advertisements